» Articles » PMID: 8413873

Duration of Intracranial Pressure Monitoring Does Not Predict Daily Risk of Infectious Complications

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 1993 Sep 1
PMID 8413873
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

A group of 205 patients (115 children and 90 adults) with a total of 212 intracranial pressure (ICP) monitors were retrospectively studied with attention to daily cerebrospinal fluid cultures, duration of monitoring, associated cranial injuries, and hospital site of the ICP monitor (intensive care unit or operating room). Only closed ICP monitoring systems without irrigation or compliance testing were used, and all patients received antibiotics as prophylaxis throughout the monitoring period. There were no complications associated with monitor placement. Incidence histograms and regression analysis were used to determine the daily risk of subsequent infections, in addition to evaluating the cumulative risk of infection, as has been previously described in the literature. No relation between the duration of ICP monitoring and the rate of daily infection through the period of maximal monitoring (1-2 weeks) was found in this series. The overall incidence of infection was 7.1% with a median duration of monitoring of 7.2 days. The age of the patient (adult vs. child), site of ICP monitor placement, and nature of the underlying disease (trauma vs. nontrauma) had no significant effect on the development of monitor-related infections in our study. These data indicate that the decision to continue ICP monitoring can be based solely on the clinical necessity for further monitoring rather than on concerns for monitor removal to prevent infection.

Citing Articles

Escalate and De-Escalate Therapies for Intracranial Pressure Control in Traumatic Brain Injury.

Battaglini D, Anania P, Rocco P, Brunetti I, Prior A, Zona G Front Neurol. 2020; 11:564751.

PMID: 33324317 PMC: 7724991. DOI: 10.3389/fneur.2020.564751.


Escalation therapy in severe traumatic brain injury: how long is intracranial pressure monitoring necessary?.

Anania P, Battaglini D, Miller J, Balestrino A, Prior A, DAndrea A Neurosurg Rev. 2020; 44(5):2415-2423.

PMID: 33215367 PMC: 7676754. DOI: 10.1007/s10143-020-01438-5.


Assessment of Bacterial Colonization of Intracranial Pressure Transducers: A Prospective Study.

Mounier R, Kapandji N, Gricourt G, Lobo D, Rodriguez C, Pons S Neurocrit Care. 2020; 34(3):814-824.

PMID: 32929599 PMC: 7490114. DOI: 10.1007/s12028-020-01096-x.


A cost effectiveness based safety and efficacy study of resterilized intra-parenchymal catheter based intracranial pressure monitoring in developing world.

Gupta D, Bisht A, Batra P, Mathur P, Mahapatra A Asian J Neurosurg. 2016; 11(4):416-420.

PMID: 27695548 PMC: 4974969. DOI: 10.4103/1793-5482.165785.


Hydrogel-coated ventricular catheters for high-risk patients receiving ventricular peritoneum shunt.

Xu H, Huang Y, Jiao W, Sun W, Li R, Li J Medicine (Baltimore). 2016; 95(29):e4252.

PMID: 27442653 PMC: 5265770. DOI: 10.1097/MD.0000000000004252.